Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Anaphylaxis Market Be Worth By 2029?

The market of anaphylaxis has witnessed robust growth in the past few years. It is projected to increase from $3.24 billion in 2024 to $3.5 billion in 2025, recording a compound annual growth rate (CAGR) of 8.1%. The prior growth can be linked to a surge in food allergies incidents, greater understanding of anaphylaxis, enhanced healthcare facilities, improved diagnosis and treatment procedures, and a rise in the accessibility of epinephrine auto-injectors.

The market for anaphylaxis is forecasted to experience robust growth in the forthcoming years, with an expected size of $4.78 billion in 2029, advancing at a compound annual growth rate of 8.1%. Factors contributing to this growth projection over the forecast period include a surge in urbanization and lifestyle modifications, an escalating number of anaphylaxis occurrences, an uptick in disposable incomes in developing markets, governmental contributions to allergy-related studies, and breakthroughs in emergency treatment delivery systems. Prominent trends anticipated during the forecast period encompass an enhancing demand for injectable auto-injectors, the assimilation of digital health solutions into anaphylaxis treatments, a heightened concentration on the affordability of products, an upswing in preventative treatments and vaccines, and a growing utilization of biologics for allergy therapies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21096&type=smp

Which Key Factors Are Fueling Growth In The Anaphylaxis Market?

The growing incidence of food allergies is expected to fuel the advancement of the anaphylaxis market. Reactions from the immune system to certain edibles, termed food allergies, can lead to various symptoms from mild to severe, including potentially fatal anaphylaxis. Shifts in eating habits, environmental factors, and heightened awareness and diagnostic measures contribute to the escalating incidence of food allergies. Treatments for anaphylaxis offer life-saving procedures for those suffering from food allergies by rapidly reversing extreme allergic reactions, minimizing symptoms such as swelling, respiratory difficulties, and a decrease in blood pressure, and providing immediate stabilization to avoid potentially fatal scenarios while equipping patients with strategies for prompt reactions to future allergic episodes. For example, as per the World Health Organization (WHO), a UN establishment based in Switzerland, by September 2024 about 220 million people worldwide were suffering from food allergies. A single food item can contain multiple allergens, and a person can be allergic to more than one kind of food. Furthermore, as per the Patterns and Prevalence of Adult Food Allergy (PAFA) report released by the Food Standards Agency (FSA) in May 2024, a UK-based non-ministerial department, over 30% of adults reported adverse reactions linked to food, with clinical assessments verifying food allergies in roughly 6% of adults in the UK, which equates to around 2.4 million individuals. Hence, the growing prevalence of food allergies is accelerating the growth of the anaphylaxis market.

Which Segmentation Factors Are Critical In The Anaphylaxis Market Analysis?

The anaphylaxismarket covered in this report is segmented –

1) By Drug Class: Epinephrine; Steroids; Antihistamines; Beta-antagonists; Other Drug Class

2) By Route Of Administration: Parenteral; Oral; Other Routes Of Administration

3) By Application: Food Allergy; Pollen Allergy; Dust Mites Allergy; Other Applications

Subsegments:

1) By Epinephrine: Auto-injectors; Prefilled Syringes; Vials

2) By Steroids: Corticosteroids; Glucocorticoids; Mineralocorticoids

3) By Antihistamines: H1-receptor Antagonists; H2-receptor Antagonists

4) By Beta-antagonists: Selective Beta-blockers; Non-selective Beta-blockers

5) By Other Drug Class: Leukotriene Receptor Antagonists; Mast Cell Stabilizers

What New Opportunities Are Emerging From Trends In The Anaphylaxis Market?

Key organizations in the anaphylaxis market are concentrating on the creation of innovative epinephrine nasal sprays to enhance speedy and effective medication delivery in emergency scenarios. Epinephrine nasal spray works by administering epinephrine, or adrenaline, via the nasal passages as a remedy for serious allergic episodes, including anaphylaxis. For example, ARS Pharmaceuticals, a biotechnology firm based in the US, announced in August 2024 that the FDA approved their product, Neffy (an epinephrine nasal spray). This marked the product as the first and uniquely needle-less treatment designed for type I allergic cases, including anaphylaxis. Neffy presents a non-intrusive substitute to the typical epinephrine autoinjectors and offers a potentially more approachable option for emergency medical treatment. The primary objective of Neffy is to boost patients’ willingness to utilize this medicine by eliminating the requirement for needles and facilitating the quick delivery of crucial epinephrine during severe allergic reactions.

Which Players Are Shaping The Competitive Landscape Of The Anaphylaxis Market?

Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Which Region Is Likely To Register The Fastest Growth In The Anaphylaxis Market?

North America was the largest region in the anaphylaxis market in 2024. The regions covered in the anaphylaxis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=21096&type=smp

Browse Through More Reports Similar to the Global Anaphylaxis Market 2025, By The Business Research Company

Anaphylaxis Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/anaphylaxis-treatment-global-market-report

Allergic Rhinitis Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-global-market-report

Animal Antibiotics And Antimicrobials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model